Related Articles for PubMed (Select 16719908)

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP.

BMC Neurol. 2006 May 23;6:19.

PMID: 16719908 [PubMed - indexed for MEDLINE]

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.

Neurology. 2001 Oct 9;57(7):1239-47.

PMID: 11591843 [PubMed - indexed for MEDLINE]

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID: 15089110 [PubMed - indexed for MEDLINE]

Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.

Massacesi L, Parigi A, Barilaro A, Repice AM, Pellicanò G, Konze A, Siracusa G, Taiuti R, Amaducci L.

Arch Neurol. 2005 Dec;62(12):1843-7.

PMID: 16344342 [PubMed - indexed for MEDLINE]

Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.

De Stefano N, Filippi M, Hawkins C; 9011 study group.

J Neurol Sci. 2008 Mar 15;266(1-2):44-50. Epub 2007 Sep 25.

PMID: 17897678 [PubMed - indexed for MEDLINE]

Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.

Zivadinov R, Zorzon M, De Masi R, Nasuelli D, Cazzato G.

J Neurol Sci. 2008 Apr 15;267(1-2):28-35. Epub 2007 Oct 18.

PMID: 17945260 [PubMed - indexed for MEDLINE]

A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging.

Jeffery DR, Chepuri N, Durden D, Burdette J.

Mult Scler. 2005 Jun;11(3):296-301.

PMID: 15957510 [PubMed - indexed for MEDLINE]

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.

Rao AB, Richert N, Howard T, Lewis BK, Bash CN, McFarland HF, Frank JA.

Neurology. 2002 Sep 10;59(5):688-94.

PMID: 12221158 [PubMed - indexed for MEDLINE]

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID: 16750460 [PubMed - indexed for MEDLINE]

10:

MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.

Gasperini C, Paolillo A, Giugni E, Galgani S, Bagnato F, Mainero C, Onesti E, Bastianello S, Pozzilli C.

Mult Scler. 2002 Apr;8(2):119-23.

PMID: 11990868 [PubMed - indexed for MEDLINE]

11:

Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.

Smith D.

J Neurol Sci. 2004 Aug 15;223(1):73-9.

PMID: 15261565 [PubMed - indexed for MEDLINE]

12:

Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Hoogervorst EL, Polman CH, Barkhof F.

Mult Scler. 2002 Oct;8(5):415-9.

PMID: 12356209 [PubMed - indexed for MEDLINE]

13:

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.

Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BM; REGARD study group.

Lancet Neurol. 2008 Oct;7(10):903-14. Epub 2008 Sep 11.

PMID: 18789766 [PubMed - indexed for MEDLINE]

14:

Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.

Zhao Y, Traboulsee A, Petkau AJ, Li D.

Neurology. 2008 Mar 25;70(13 Pt 2):1092-7. Epub 2007 Nov 14.

PMID: 18003938 [PubMed - indexed for MEDLINE]

15:

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H.

Mult Scler. 2005 Oct;11(5):573-82.

PMID: 16193896 [PubMed - indexed for MEDLINE]

16:

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.

Arnold DL, Campagnolo D, Panitch H, Bar-Or A, Dunn J, Freedman MS, Gazda SK, Vollmer T.

J Neurol. 2008 Oct;255(10):1473-8. Epub 2008 Oct 7.

PMID: 18854910 [PubMed - indexed for MEDLINE]

17:

The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.

Paolillo A, Piattella MC, Pantano P, Di Legge S, Caramia F, Russo P, Lenzi GL, Pozzilli C.

J Neurol. 2004 Apr;251(4):432-9.

PMID: 15083288 [PubMed - indexed for MEDLINE]

18:

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

Miller DH, Soon D, Fernando KT, MacManus DG, Barker GJ, Yousry TA, Fisher E, O'Connor PW, Phillips JT, Polman CH, Kappos L, Hutchinson M, Havrdova E, Lublin FD, Giovannoni G, Wajgt A, Rudick R, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators.

Neurology. 2007 Apr 24;68(17):1390-401.

PMID: 17452584 [PubMed - indexed for MEDLINE]

19:

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.

Comi G, Filippi M, Wolinsky JS.

Ann Neurol. 2001 Mar;49(3):290-7.

PMID: 11261502 [PubMed - indexed for MEDLINE]

20:

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis.

Dalton CM, Miszkiel KA, Barker GJ, MacManus DG, Pepple TI, Panzara M, Yang M, Hulme A, O'Connor P, Miller DH.

J Neurol. 2004 Apr;251(4):407-13.

PMID: 15083284 [PubMed - indexed for MEDLINE]

Recent Activity